Literature DB >> 8542090

Overexpression of c-myc messenger RNA in primary and metastatic lesions of carcinoma of the stomach.

N Onoda1, K Maeda, Y S Chung, Y Yano, I Matsui-Yuasa, S Otani, M Sowa.   

Abstract

BACKGROUND: Although c-myc expression in carcinoma of the stomach has been reported to be involved in progression of the disease, little is known about the mechanism or significance of its expression. STUDY
DESIGN: We measured c-myc messenger RNA (mRNA) levels by Northern blot hybridization in 51 primary gastric carcinoma lesions and 15 metastatic lesions accompanied by normal mucosal tissues from the same patients. The extent of c-myc mRNA expression in malignant lesions was determined and compared with that in normal mucosal tissues. The clinical and pathologic significance of c-myc mRNA expression was investigated.
RESULTS: In 35 (68.6 percent) of 51 primary gastric carcinomas c-myc mRNA was overexpressed. Expression was found to be more frequent and stronger in early lesions than in advanced lesions (90 percent, 6.15-fold compared with 54.8 percent, 2.42-fold, p < 0.05). However, c-myc mRNA expression in the primary lesions showed little influence on either the histologic features or the disease progression. C-myc mRNA levels were higher in every metastatic lesion than in the primary lesions (9.89-fold compared with 3.04-fold, p < 0.05).
CONCLUSIONS: These observations suggest that c-myc mRNA overexpression may play a role in the early development of primary lesions as well as in the formation of metastatic lesions of carcinomas of the stomach.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8542090

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  11 in total

1.  The impact of C-MYC gene expression on gastric cancer cell.

Authors:  Lin Zhang; Yanhong Hou; Hassan Ashktorab; Liucun Gao; Yanjie Xu; Kai Wu; Junshan Zhai; Lei Zhang
Journal:  Mol Cell Biochem       Date:  2010-08-25       Impact factor: 3.396

2.  Pdcd4 knockdown up-regulates MAP4K1 expression and activation of AP-1 dependent transcription through c-Myc.

Authors:  Qing Wang; Yan Zhang; Hsin-Sheng Yang
Journal:  Biochim Biophys Acta       Date:  2012-07-16

3.  The therapeutic effects of recombinant adenovirus RA538 on human gastric carcinoma cells in vitro and in vivo.

Authors:  Jie-Ping Chen; Chen Lin; Cai-Pu Xu; Xue-Yan Zhang; Ming Wu
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

4.  The overexpression of AP-4 as a prognostic indicator for gastric carcinoma.

Authors:  Liu Xinghua; Zhang Bo; Guo Yan; Wu Lei; Wu Changyao; Liang Qi; Ye Lin; Tao Kaixiong; Wang Guobin; Chen Jianying
Journal:  Med Oncol       Date:  2011-02-20       Impact factor: 3.064

5.  The role of oncogenes in gastrointestinal cancer.

Authors:  Emmanouil P Pappou; Nita Ahuja
Journal:  Gastrointest Cancer Res       Date:  2010-11

Review 6.  MYC and gastric adenocarcinoma carcinogenesis.

Authors:  Danielle-Queiroz Calcagno; Mariana-Ferreira Leal; Paulo-Pimentel Assumpcao; Marilia-Arruda-Cardoso Smith; Rommel-Rodriguez Burbano
Journal:  World J Gastroenterol       Date:  2008-10-21       Impact factor: 5.742

7.  Association Between Amplification and Expression of C-MYC Gene and Clinicopathological Characteristics of Stomach Cancer.

Authors:  Malihea Khaleghian; Issa Jahanzad; Abbas Shakoori; Amirnader Emami Razavi; Cyrus Azimi
Journal:  Iran Red Crescent Med J       Date:  2016-01-01       Impact factor: 0.611

8.  Study of C-MYC amplification and expression in Iranian gastric cancer samples using CISH and IHC methods.

Authors:  Malihea Khaleghian; Issa Jahanzad; Abbas Shakoori; Farid Azmoudeh Ardalan; Cyrus Azimi
Journal:  Adv Biomed Res       Date:  2015-05-29

9.  Chromosome 8q as the most frequent target for amplification in early gastric carcinoma.

Authors:  Ji Un Kang
Journal:  Oncol Lett       Date:  2014-02-03       Impact factor: 2.967

10.  The diagnostic value of serum gastrokine 1 (GKN1) protein in gastric cancer.

Authors:  Jung Hwan Yoon; Yong Gyu Park; Suk Woo Nam; Won Sang Park
Journal:  Cancer Med       Date:  2019-08-03       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.